Story · Medicine & Biotech
Successful Lipid Lowering With Alirocumab and Bempedoic Acid in a Statin-Intolerant Heterozygous Familial Hypercholesterolemia With Markedly Elevated Lipoprotein(a): A Case Report
1 outlet · first reported by Cureus on
Intensive lipid lowering is essential in the management of heterozygous familial hypercholesterolaemia (HeFH). Statin intolerance necessitates consideration of alternative lipid-lowering therapies, while concomitantly elevated lipoprotein(a) (Lp(a)) further increases cardiovascular risk and the… (Cureus)
Coverage, in order
-
Successful Lipid Lowering With Alirocumab and Bempedoic Acid in a Statin-Intolerant Heterozygous Familial Hypercholesterolemia With Markedly Elevated Lipoprotein(a): A Case Report
Intensive lipid lowering is essential in the management of heterozygous familial hypercholesterolaemia (HeFH). Statin intolerance necessitates consideration of alternative lipid-lowering therapies, while concomitantly elevated lipoprotein(a) (Lp(a)) further increases cardiovascular risk and the…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.